The role of PGP9.5 as a tumor suppressor gene in human cancer

Yutaka Tokumaru, Keishi Yamashita, Sook Kim Myoung, Hannah L. Park, Motonobu Osada, Masaki Mori, David Sidransky

Research output: Contribution to journalArticle

44 Citations (Scopus)

Abstract

PGP9.5 is a controversial molecule from an oncologic point of view. We recently identified frequent methylation of PGP9.5 gene exclusively in primary head and neck squamous cell carcinoma (HNSCC), suggesting that it could be a tumor suppressor gene. On the other hand, PGP9.5 was reported to be overexpressed in a subset of human cancers presumably due to intrinsic oncogenic properties or as a result of transformation. To demonstrate that PGP9.5 possesses tumor suppressive activity, we examined forced expression by stable transfection of PGP9.5 in 4 HNSCC cell lines. Although all 4 cell lines demonstrated reduced log growth rates in culture after transfection, only 2 cell lines with wild type p53 (011, 022) demonstrated decreased growth in soft agar. In 2 cell lines with mutant p53 (013, 019), we observed no altered growth in soft agar and increased sensitivity to UV irradiation. We then tested for and found a high frequency of promoter methylation in a larger panel of primary tumors including HNSCC, esophageal SCC, gastric, lung, prostate and hepatocellular carcinoma. Our data support the notion that PGP9.5 is a tumor suppressor gene that is inactivated by promoter methylation or gene deletion in several types of human cancers.

Original languageEnglish
Pages (from-to)753-759
Number of pages7
JournalInternational Journal of Cancer
Volume123
Issue number4
DOIs
Publication statusPublished - Aug 15 2008

Fingerprint

Tumor Suppressor Genes
Methylation
Cell Line
Agar
Transfection
Neoplasms
Growth
Gene Deletion
Prostate
Hepatocellular Carcinoma
Stomach
Lung
Genes
Carcinoma, squamous cell of head and neck

All Science Journal Classification (ASJC) codes

  • Oncology
  • Cancer Research

Cite this

Tokumaru, Y., Yamashita, K., Myoung, S. K., Park, H. L., Osada, M., Mori, M., & Sidransky, D. (2008). The role of PGP9.5 as a tumor suppressor gene in human cancer. International Journal of Cancer, 123(4), 753-759. https://doi.org/10.1002/ijc.23354

The role of PGP9.5 as a tumor suppressor gene in human cancer. / Tokumaru, Yutaka; Yamashita, Keishi; Myoung, Sook Kim; Park, Hannah L.; Osada, Motonobu; Mori, Masaki; Sidransky, David.

In: International Journal of Cancer, Vol. 123, No. 4, 15.08.2008, p. 753-759.

Research output: Contribution to journalArticle

Tokumaru, Y, Yamashita, K, Myoung, SK, Park, HL, Osada, M, Mori, M & Sidransky, D 2008, 'The role of PGP9.5 as a tumor suppressor gene in human cancer', International Journal of Cancer, vol. 123, no. 4, pp. 753-759. https://doi.org/10.1002/ijc.23354
Tokumaru Y, Yamashita K, Myoung SK, Park HL, Osada M, Mori M et al. The role of PGP9.5 as a tumor suppressor gene in human cancer. International Journal of Cancer. 2008 Aug 15;123(4):753-759. https://doi.org/10.1002/ijc.23354
Tokumaru, Yutaka ; Yamashita, Keishi ; Myoung, Sook Kim ; Park, Hannah L. ; Osada, Motonobu ; Mori, Masaki ; Sidransky, David. / The role of PGP9.5 as a tumor suppressor gene in human cancer. In: International Journal of Cancer. 2008 ; Vol. 123, No. 4. pp. 753-759.
@article{10f110ace7ec4df6bcf88fa6fecf1aa9,
title = "The role of PGP9.5 as a tumor suppressor gene in human cancer",
abstract = "PGP9.5 is a controversial molecule from an oncologic point of view. We recently identified frequent methylation of PGP9.5 gene exclusively in primary head and neck squamous cell carcinoma (HNSCC), suggesting that it could be a tumor suppressor gene. On the other hand, PGP9.5 was reported to be overexpressed in a subset of human cancers presumably due to intrinsic oncogenic properties or as a result of transformation. To demonstrate that PGP9.5 possesses tumor suppressive activity, we examined forced expression by stable transfection of PGP9.5 in 4 HNSCC cell lines. Although all 4 cell lines demonstrated reduced log growth rates in culture after transfection, only 2 cell lines with wild type p53 (011, 022) demonstrated decreased growth in soft agar. In 2 cell lines with mutant p53 (013, 019), we observed no altered growth in soft agar and increased sensitivity to UV irradiation. We then tested for and found a high frequency of promoter methylation in a larger panel of primary tumors including HNSCC, esophageal SCC, gastric, lung, prostate and hepatocellular carcinoma. Our data support the notion that PGP9.5 is a tumor suppressor gene that is inactivated by promoter methylation or gene deletion in several types of human cancers.",
author = "Yutaka Tokumaru and Keishi Yamashita and Myoung, {Sook Kim} and Park, {Hannah L.} and Motonobu Osada and Masaki Mori and David Sidransky",
year = "2008",
month = "8",
day = "15",
doi = "10.1002/ijc.23354",
language = "English",
volume = "123",
pages = "753--759",
journal = "International Journal of Cancer",
issn = "0020-7136",
publisher = "Wiley-Liss Inc.",
number = "4",

}

TY - JOUR

T1 - The role of PGP9.5 as a tumor suppressor gene in human cancer

AU - Tokumaru, Yutaka

AU - Yamashita, Keishi

AU - Myoung, Sook Kim

AU - Park, Hannah L.

AU - Osada, Motonobu

AU - Mori, Masaki

AU - Sidransky, David

PY - 2008/8/15

Y1 - 2008/8/15

N2 - PGP9.5 is a controversial molecule from an oncologic point of view. We recently identified frequent methylation of PGP9.5 gene exclusively in primary head and neck squamous cell carcinoma (HNSCC), suggesting that it could be a tumor suppressor gene. On the other hand, PGP9.5 was reported to be overexpressed in a subset of human cancers presumably due to intrinsic oncogenic properties or as a result of transformation. To demonstrate that PGP9.5 possesses tumor suppressive activity, we examined forced expression by stable transfection of PGP9.5 in 4 HNSCC cell lines. Although all 4 cell lines demonstrated reduced log growth rates in culture after transfection, only 2 cell lines with wild type p53 (011, 022) demonstrated decreased growth in soft agar. In 2 cell lines with mutant p53 (013, 019), we observed no altered growth in soft agar and increased sensitivity to UV irradiation. We then tested for and found a high frequency of promoter methylation in a larger panel of primary tumors including HNSCC, esophageal SCC, gastric, lung, prostate and hepatocellular carcinoma. Our data support the notion that PGP9.5 is a tumor suppressor gene that is inactivated by promoter methylation or gene deletion in several types of human cancers.

AB - PGP9.5 is a controversial molecule from an oncologic point of view. We recently identified frequent methylation of PGP9.5 gene exclusively in primary head and neck squamous cell carcinoma (HNSCC), suggesting that it could be a tumor suppressor gene. On the other hand, PGP9.5 was reported to be overexpressed in a subset of human cancers presumably due to intrinsic oncogenic properties or as a result of transformation. To demonstrate that PGP9.5 possesses tumor suppressive activity, we examined forced expression by stable transfection of PGP9.5 in 4 HNSCC cell lines. Although all 4 cell lines demonstrated reduced log growth rates in culture after transfection, only 2 cell lines with wild type p53 (011, 022) demonstrated decreased growth in soft agar. In 2 cell lines with mutant p53 (013, 019), we observed no altered growth in soft agar and increased sensitivity to UV irradiation. We then tested for and found a high frequency of promoter methylation in a larger panel of primary tumors including HNSCC, esophageal SCC, gastric, lung, prostate and hepatocellular carcinoma. Our data support the notion that PGP9.5 is a tumor suppressor gene that is inactivated by promoter methylation or gene deletion in several types of human cancers.

UR - http://www.scopus.com/inward/record.url?scp=47049095886&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=47049095886&partnerID=8YFLogxK

U2 - 10.1002/ijc.23354

DO - 10.1002/ijc.23354

M3 - Article

C2 - 18512240

AN - SCOPUS:47049095886

VL - 123

SP - 753

EP - 759

JO - International Journal of Cancer

JF - International Journal of Cancer

SN - 0020-7136

IS - 4

ER -